Printer Friendly

THREE MEDICAL EXPERTS TESTIFY EMF POSE NO HEALTH THREAT

 THREE MEDICAL EXPERTS TESTIFY EMF POSE NO HEALTH THREAT
 PHILADELPHIA, Nov. 22 /PRNewswire/ -- Three medical experts


testified in Philadelphia this week before a Pennsylvania Public Utility Commission (PUC) Administrative Law Judge that they believe electric and magnetic fields (EMF) pose no threat to human health.
 They testified on behalf of Philadelphia Electric Company (NYSE: PE) at a hearing concerning whether there would be any adverse health effects caused by EMF in the vicinity of a 12.8-mile, $19.8 million, 230,000-volt transmission line being rebuilt between PE's Woodbourne substation in Middletown Township, Bucks County, and its Heaton substation in Upper Moreland Township, Montgomery County.
 Dr. Richard Bockman testified, "There is adequate experimental data to show that EMF do not adversely affect complex endocrine system function needed for successful reproduction, growth or development.
 "My overall conclusion is that there is no basis to conclude that power frequency electric and/or magnetic fields have adverse effects on the health and function of the endocrine or immune systems."
 Bockman, who holds an M.D. from Yale University and a Ph.D. in biochemistry from Rockefeller University, is head of the endocrine service at the Hospital for Special Surgery, and professor of medicine, at the Cornell University Medical College, as well as adjunct associate attending physician at the Memorial Sloan-Kettering Cancer Center.
 Dr. Philip Cole testified, "Taken together, the epidemiological reports fail to demonstrate any strong or consistent pattern of association between EMF and cancer among human beings.
 "Indeed, even among the positive studies, findings are not supported by the internal characteristics of the data. The summation can only be that, to date, there is no demonstrated relationship between EMF and cancer in human beings."
 Asked whether persons residing near the Woodbourne-Heaton line would have an increased risk of cancer, he replied: "Since I am of the opinion that EMFs have not been demonstrated to be carcinogenic, I believe that the transmission line poses no threat of cancer to persons in its vicinity."
 Cole, who holds a masters and a doctorate of public health in epidemiology from Harvard University, is professor and chairman of the Department of Epidemiology, School of Public Health at the Comprehensive Cancer Center of the University of Alabama at Birmingham.
 Dr. Edward Gelmann, when asked if EMF studies involving biological effects support the hypothesis that exposure to power frequency fields is related to cancer, replied: "No. The number of biological endpoints is not the relevant issue. The question is whether the processes that are involved are related to an adverse health outcome.
 "To illustrate, breathing fresh air causes an immense number of biological effects in the human, but the process of breathing does not cause cancer or other adverse health effects. The argument that biological effects must lead to adverse health is contrary to basic biological and medical facts."
 He testified further, "The extensive research on molecular and cellular biology and cancer provides no scientific basis to conclude that power frequency electric and/or magnetic fields cause, promote or contribute to the development of cancer or other adverse health effects.
 "This is consistent with the conclusions reached by independent scientific commissions and agencies that have reviewed this research."
 Asked if there is any scientific basis to conclude that EMF from the Woodbourne-Heaton line would cause adverse health effects, including cancer, he replied: "No, there is not."
 Gelmann, who graduated magna cum laude from Yale University and holds an M.D. from the Stanford University School of Medicine, is professor of medicine and chief of the Division of Medical Oncology at the Georgetown University School of Medicine.
 The Woodbourne-Heaton line, which PE is constructing to accommodate the rapidly expanding electrical needs and assure service reliability for growing customer demand in Bucks and Montgomery Counties, is almost completed and will be ready to be energized in the spring of 1992.
 However, some residents living near the line in Bucks County requested hearings, primarily on EMF, prior to the activation of the line.
 The hearings, before PUC ALJ Herbert Smolen, began in August and are scheduled at least through December.
 /delval/
 -0- 11/22/91
 /CONTACT: Bill Jones of Philadelphia Electric, 215-841-4129/
 (PE) CO: Philadelphia Electric Company ST: Pennsylvania IN: UTI SU:


CC -- PH020 -- 6387 11/22/91 12:28 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 22, 1991
Words:709
Previous Article:OCEANEERING INTERNATIONAL TO LIST ON NEW YORK STOCK EXCHANGE
Next Article:TEKTRONIX SPINS OFF BUSINESS UNIT, FORMING CACHE SCIENTIFIC; SUBSIDIARY SEEN AS LEADING SUPPLIER IN COMPUTER-AIDED CHEMISTRY MARKET
Topics:


Related Articles
NO APPEAL IN WORLD'S FIRST EMF/CANCER CASE
JURY SELECTION UNDER WAY IN EMF TRIAL -- McCARTIN V. SDG&E
SEATTLE CITY LIGHT: STATE APPEALS JUDGE REAFFIRMS 1992 DECISION ON EMF WORKERS CLAIM
JURY FINDS FOR SDG&E IN LANDMARK EMF PROPERTY VALUE TRIAL
JUDGE AFFIRMS JURY'S VERDICT IN LANDMARK EMF TRIAL
Concern mounts about electromagnetic fields; media accused of poor coverage.
NOBEL LAUREATES, AMA TAKE STAND ON EMF; GROUPS CONTEND NO ASSOCIATION HAS BEEN FOUND BETWEEN EMF AND CANCER
Attitudes about electric and magnetic fields: do scientists and other risk experts perceive risk similarly? (Practical Stuff!).

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters